GlassScriptPhysician profile
David Napoliello
NPI 1326049834
$8,640.12
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $435 · 2020: $6,371 · 2021: $1,274 · 2022: $362 · 2023: $26.46 · 2024: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $198.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,679.72 | 2019-2022 | |
| Tela Bio, INC. | $201.75 | 2019-2024 | Ovitex 2s |
| Sanara Medtech INC. | $150.40 | 2022 | |
| Allergan, INC. | $124.53 | 2019 | |
| Endogastric Solutions, INC | $106.00 | 2020 | |
| Davol INC. | $101.02 | 2019-2020 | |
| Ethicon US, LLC | $74.26 | 2019-2023 | Echelon Circular |
| Becton, Dickinson and Company | $48.78 | 2022 | |
| Smith+Nephew, INC. | $47.87 | 2022-2024 | Stravix Pl, Grafix Pl |
| Baxter Healthcare | $30.24 | 2024 | Tisseel |
| Covidien LP | $17.94 | 2019 | |
| Kci USA, INC. | $16.98 | 2021 | |
| Triad Life Sciences INC. | $14.18 | 2022 | |
| Innocoll Pharmaceuticals Limited | $13.61 | 2021 | |
| Teleflex LLC | $12.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Napoliello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.